NCT04377477View on ClinicalTrials.gov

COVID-19 Pneumonitis Low Dose Lung Radiotherapy (COLOR-19)

NACompletedINTERVENTIONAL
Enrollment

3

Participants

Timeline

Start Date

May 10, 2020

Primary Completion Date

March 10, 2022

Study Completion Date

May 30, 2022

Conditions
COVID-19
Interventions
RADIATION

Single fraction whole lung radiotherapy

Participants will undergo irradiation of the lungs, administered in a single fraction at the average prescription dose of 0.7 Gy

Trial Locations (1)

25123

Radiation Oncology Department, ASST SpedaliCivili, Brescia, Brescia

All Listed Sponsors
lead

Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia

OTHER

NCT04377477 - COVID-19 Pneumonitis Low Dose Lung Radiotherapy (COLOR-19) | Biotech Hunter | Biotech Hunter